Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jul, 3 2026
May, 8 2026
May, 5 2026
Jun, 9 2026
Jan, 15 2026